Evidence map›Paper›PMID 42352437›Full record

ArticleCancers2026

Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting.

Scott F Huntington, Justin T Puckett, Beenish S Manzoor, Nnadozie Emechebe, Sophia S Li, Sachin Kamal-Bahl, Carolina Reyes, Holly Budlong, Jalpa A Doshi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Scott F HuntingtonSchool of Medicine, Yale University, 37 College St., Rm 141, New Haven, CT 06520-8073, USA.
Justin T PuckettCOVIA Health Solutions, Lansdale, PA 19446, USA.
Beenish S ManzoorAbbVie Inc., North Chicago, IL 60064, USA.
Nnadozie EmechebeAbbVie Inc., North Chicago, IL 60064, USA.
Sophia S LiGenentech Inc., South San Francisco, CA 94080, USA.ORCID 0000-0002-5235-8237
Sachin Kamal-BahlCOVIA Health Solutions, Lansdale, PA 19446, USA.
Carolina ReyesGenentech Inc., South San Francisco, CA 94080, USA.
Holly BudlongAbbVie Inc., North Chicago, IL 60064, USA.
Jalpa A DoshiUniversity of Pennsylvania, Philadelphia, PA 19104, USA.

Funding

AbbVie Inc N/AGenentech Inc. N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bruton tyrosine kinase inhibitorschronic lymphocytic leukemiafrontline therapyMedicarereal-world outcomessurvivalvenetoclax

Identifiers

PMID42352437
PMCPMC13297127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.